Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide. Nakagawa-Saito Y, Mitobe Y, Togashi K, Suzuki S, et al. Anticancer Res 2023;43:1131-1138.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakagawa-Saito Y, Mitobe Y, Togashi K, Suzuki S, et al. Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide. Anticancer Res 2023;43:1131-1138.
PMID: 36854532